Company Quick10K Filing
ENB Financial
10-Q 2021-03-31 Filed 2021-05-14
10-K 2020-12-31 Filed 2021-03-29
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-29
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-29
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-13
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-29
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-25
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-25
8-K 2021-01-20 Other Events, Exhibits
8-K 2021-01-13 Earnings, Exhibits
8-K 2020-12-30 Enter Agreement, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2020-10-21
8-K 2020-10-15
8-K 2020-10-02
8-K 2020-07-15
8-K 2020-07-14
8-K 2020-06-02
8-K 2020-05-05
8-K 2020-04-15
8-K 2020-04-13
8-K 2020-04-03
8-K 2020-01-15
8-K 2020-01-14
8-K 2019-10-16
8-K 2019-10-11
8-K 2019-07-17
8-K 2019-07-17
8-K 2019-06-03
8-K 2019-05-15
8-K 2019-05-07
8-K 2019-04-17
8-K 2019-04-12
8-K 2019-04-01
8-K 2019-02-20
8-K 2019-01-31
8-K 2019-01-16
8-K 2019-01-15
8-K 2018-10-18
8-K 2018-10-17
8-K 2018-10-15
8-K 2018-07-19
8-K 2018-07-18
8-K 2018-05-08
8-K 2018-04-18
8-K 2018-04-16
8-K 2018-02-02
8-K 2018-01-18
8-K 2018-01-17

ENB Financial Financials

ENBP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3532333535363442302538454443403740444151505956445338442841405241
Accounts Receivable
Inventory
PP&E2121212121362122224023232340222222412122232424244826262649252525
Assets7697717687777857997998127958128258508518578638708649069259409711,0081,0121,0101,0341,0301,0501,0621,0981,1121,1321,146
Accounts Payable
Long-Term Debt8073767370736868656565696262666765606562645965686669686865727580
Liabilities6876896856906967107097287107287387617597647687777708108288408719119129099349339519639951,0051,0191,030
Stockholders' Equity8282848689908984848487909193959395959710010096100101100989999103107113116
Income Statement ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A0000000000000000000000000000000
Tax0000000011000000010001010000011
Net Income22222222222222122222222213332333
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1-42612423215-4222312313454237
Cash Investing23-4-8-15-3-7-2-262-15-3-7-8-13-38-23-3-32-10-4-19-17-17-31-11-5-27
Cash Financing-625215011-1217922-2-32384017122921-024-3181081310